November 1, 2025 · Form 4 insider transaction
Caudill Cortney sold 4,263 shares of Halozyme Therapeutics, Inc. at $65.19 per share, a transaction worth $277.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 48 days after the transaction.
The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations.